Introduction: Indium is a relatively rare element that has been used for decades as a metal, in alloys, and for electronics applications. More recently, indium-tin oxide (ITO), a sintered material typically consisting of 90% indium oxide (In2O3) and 10% tin oxide (SnO2), has been used for the production of flat panel displays including liquid crystal displays. Methods: We reviewed documents available through a state workers' compensation system to identify indium-exposed workers with lung disease. Additional medical records were solicited from pulmonologists and occupational medicine physicians. We conducted literature reviews of indium toxicity and pulmonary alveolar proteinosis. Results: From 2000-2007, four male workers producing or recycling ITO at one facility developed radiographically-evident lung disease. The facility's ITO workforce consisted of approximately 15 people. Age of affected workers ranged from 28-51 years. Two of the workers presented with chest symptoms and were diagnosed with pulmonary alveolar proteinosis on the basis of lung tissue specimens showing granular, Periodic acid-Schiff (PAS)-positive intraalveolar material and cholesterol clefts; one of these cases was fatal. One worker with pulmonary alveolar proteinosis was tested for autoantibodies to granulocyte-macrophage colony-stimulating factor (GM-CSF) and found to have an elevated level (52.9 mu/ml; normal <3 mu/ml). Both workers with pulmonary alveolar proteinosis had indium detected in lung tissue specimens. A third worker with chest symptoms had abnormalities on high resolution computed tomography (HRCT) scan of the chest, including diffuse 1 mm centrilobular nodules, areas of ground glass opacity, and extensive interlobular septal thickening. A fourth worker who was asymptomatic had HRCT showing mild diffuse prominence of interstitial markings. We found previous reports of exposure to indium resulting in pulmonary pathology, including animal studies showing alveolar proteinosis and two cases of interstitial lung disease in ITO-exposed workers in Japan. While most cases of adult pulmonary alveolar proteinosis are considered to be primary, cases have been reported in association with other occupational and environmental exposures. Conclusions: These cases suggest that inhalational exposure to ITO causes pulmonary alveolar proteinosis, as part of a spectrum of lung disease that includes interstitial lung disease. The detection of autoantibodies to GM-CSF in one of the cases of ITO-related pulmonary alveolar proteinosis indicates an autoimmune disease mechanism. Clinicians should be alert to the potential for pulmonary toxicity with ITO exposure, and effective control measures should be determined and implemented in workplaces where ITO is used.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.